Blood Cancers Completed Phase 2 Trials for Antithymocyte immunoglobulin (rabbit) (DB00098)

Also known as: Blood Cancer

IndicationStatusPhase
DBCOND0048268 (Blood Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00185640Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic MalignanciesTreatment